An international research team has developed microscopic particles that can restore light sensitivity to blind retinas in a preclinical study. The nanoparticles are injected directly into the eye, where they settle close to the retina's nerve cells. Once in place, they function as artificial light receptors, responding to incoming light.
When light strikes the particles, they appear to activate nearby retinal neurons, effectively bypassing damaged or lost natural photoreceptors. The study, reported by Phys.org, suggests a potential new strategy for treating retinal degeneration, though the work remains at an early experimental stage.
The findings are based on a single source, so no independent confirmation or conflicting results are noted. Further research will be needed to determine safety and effectiveness before any clinical application.